The early downregulation of liver Igf1 expression without affecting plasma glucose levels suggested a hyperglycemia-independent suppression of liver Igf1 mRNA expression in this model, likely due to the hypoinsulinemia resulting in decreased insulin signaling in the liver. The gene discussed is INS; the disease is Hyperglycemia.